P. Menasche et al., EFFICACY OF LACTOBIONATE-ENRICHED CARDIOPLEGIC SOLUTION IN PRESERVINGCOMPLIANCE OF COLD-STORED HEART-TRANSPLANTS, The Journal of heart and lung transplantation, 12(6), 1993, pp. 1053-1061
Cardioplegic solutions of the extracellular type are commonly used as
storage media for heart transplants. Because this type of formulation
was not originally designed for preventing hypothermically induced ede
ma, we assessed the effects of supplementing a standard, extracellular
-like cardioplegic solution with the high molecular weight impermeant
lactobionate on water content and postischemic compliance of isolated
rat hearts. In one series of experiments, hearts were immersed in eith
er a standard cardioplegic solution of the extracellular type or in th
e same solution supplemented with lactobionate (80 mmol/L). Hearts wer
e then processed for measurements of water content after 4 hours, 6 ho
urs, and 8 hours of storage at 4-degrees-C. In a second series of expe
riments, hearts were stored in the same solutions for 4 hours and 8 ho
urs and subsequently reperfused for 1 hour on a Langendorff column, at
which time left ventricular pressure-volume curves were constructed a
nd compared with those obtained during the preischemic perfusion. Lact
obionate-treated hearts gained significantly less water than controls
after 4 hours and 6 hours of storage, but the difference was no longer
significant at the 8-hour time point. In contrast, the treated group
yielded a significantly better recovery of compliance after both 4 hou
rs and 8 hours of storage, suggesting that lactobionate might exert pr
otective effects in addition to those caused by its impermeant propert
ies, possibly involving calcium chelation and subsequent limitation of
calcium-dependent contracture. Extracellular-type cardioplegic soluti
ons are attractive because a single solution can be used during all ph
ases of the transplantation procedure. Our results suggest, however, t
hat for enhancing their effectiveness in preserving compliance of card
iac grafts, their formulation needs to be tailored to the specific nee
ds of the cold-stored heart, which implies, among other things, that i
t incorporates high molecular weight impermeants.